VERO Biotech’s GENOSYL® Delivery System recognized as a “Technological Breakthrough” at Premier, Inc.’s Annual Supplier Innovation Celebration

Vero will be honored as an “Innovative Supplier” at Premier’s Annual Breakthroughs Conference and Exhibition (BREAKTHROUGHS 2023) taking place June 20-22 in Nashville, TN

June 14, 2023 – Atlanta, GA – VERO Biotech Inc., a commercial-stage healthcare business dedicated to neonatal intensive care and the acute care hospital community, today announced that it will be honored during Premier, Inc.’s annual supplier Innovation Celebration at the 2023 Breakthroughs Conference and Exhibition.

VERO Biotech’s GENOSYL® Delivery System (DS) will be recognized as a “Technological Breakthrough.” VERO Biotech’s GENOSYL® DS – the first tankless nitric oxide delivery system approved by the FDA – will be one of only seven innovations honored during Premier’s supplier Innovation Celebration, which recognizes groundbreaking healthcare technologies that have been launched throughout the year and the ways these products are helping to improve the health of communities. 

“We are honored to receive this recognition from Premier. We are deeply committed to continued innovation so that we may better serve patients, respiratory therapists, and healthcare providers.” said Brent V. Furse, CEO and President, VERO Biotech


Click here to view original post